These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11547915)

  • 1. D-chiro-inositol in insulin action and insulin resistance-old-fashioned biochemistry still at work.
    Larner J
    IUBMB Life; 2001 Mar; 51(3):139-48. PubMed ID: 11547915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances in the research on insulin mediators].
    Guo KQ
    Zhonghua Yi Xue Za Zhi; 1993 Jan; 73(1):54-6. PubMed ID: 8389235
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of insulin action.
    Espinal J
    Nature; 1987 Aug 13-19; 328(6131):574-5. PubMed ID: 3112581
    [No Abstract]   [Full Text] [Related]  

  • 4. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.
    Sun TH; Heimark DB; Nguygen T; Nadler JL; Larner J
    Biochem Biophys Res Commun; 2002 May; 293(3):1092-8. PubMed ID: 12051772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy.
    Larner J; Allan G; Kessler C; Reamer P; Gunn R; Huang LC
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):127-37. PubMed ID: 10212830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?
    Rademacher TW; Gumaa K; Scioscia M
    J Reprod Immunol; 2007 Dec; 76(1-2):78-84. PubMed ID: 17537518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin signaling in health and disease.
    White MF
    Science; 2003 Dec; 302(5651):1710-1. PubMed ID: 14657487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible post-receptor defects in NIDDM: second messengers.
    Saltiel AR
    Prog Clin Biol Res; 1988; 265():43-51. PubMed ID: 3043446
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular basis of insulin action.
    González-Sánchez JL; Serrano-Ríos M
    Drug News Perspect; 2007 Oct; 20(8):527-31. PubMed ID: 18080040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myoinositol--alternative treatment of insulin resistance in adolescents].
    Kedikova S; Sirakov M; Boyadzhieva M
    Akush Ginekol (Sofiia); 2011; 50(7):16-9. PubMed ID: 22452173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old biliverdin reductase: links to insulin resistance and may be a novel therapeutic target.
    Wu B; Liu X; Shen J
    Med Hypotheses; 2008; 71(1):73-6. PubMed ID: 18395354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin resistance in type 2 diabetes as a microdomain syndrome].
    Inokuchi JI; Igarashi Y
    Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1179-83. PubMed ID: 12807027
    [No Abstract]   [Full Text] [Related]  

  • 13. D-chiro-inositol glycans in insulin signaling and insulin resistance.
    Larner J; Brautigan DL; Thorner MO
    Mol Med; 2010; 16(11-12):543-52. PubMed ID: 20811656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative metabolic role of d-chiro inositol phosphoglycan in human pregnancy and preeclampsia.
    Scioscia M; Nigro M; Montagnani M
    J Reprod Immunol; 2014 Mar; 101-102():140-147. PubMed ID: 23962711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G(q/11) is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: co-localization of G(q/11) with the insulin receptor in membrane vesicles.
    Sleight S; Wilson BA; Heimark DB; Larner J
    Biochem Biophys Res Commun; 2002 Jul; 295(2):561-9. PubMed ID: 12150987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxa2, a novel transcriptional regulator of insulin sensitivity.
    Puigserver P; Rodgers JT
    Nat Med; 2006 Jan; 12(1):38-9. PubMed ID: 16397559
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphorylation of IRS proteins, insulin action, and insulin resistance.
    Boura-Halfon S; Zick Y
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E581-91. PubMed ID: 18728222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects.
    Asplin I; Galasko G; Larner J
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5924-8. PubMed ID: 8392181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemistry and biochemistry of type 2 diabetes.
    Ross SA; Gulve EA; Wang M
    Chem Rev; 2004 Mar; 104(3):1255-82. PubMed ID: 15008623
    [No Abstract]   [Full Text] [Related]  

  • 20. [The insulin receptor].
    de Vries CP; van Haeften TW; Wieringa TJ; van der Veen EA
    Ned Tijdschr Geneeskd; 1990 May; 134(18):891-5. PubMed ID: 2189071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.